Moleculin Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 239.92 K | $127.16 K | 675.56% | 1.55% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 208.21 K | $110.35 K | 656.30% | 1.34% |
| HRT FINANCIAL LP | 11/14/2025 | 115.19 K | $61.00 K | 100.00% | 0.74% |
| LPL FINANCIAL LLC | 11/12/2025 | 58.08 K | $30.78 K | 3.57% | 0.37% |
| IEQ CAPITAL, LLC | 11/14/2025 | 36.36 K | $19.27 K | 100.00% | 0.23% |
| WEALTH DIMENSIONS GROUP, LTD. | 10/30/2025 | 20.00 K | $10.60 K | 100.00% | 0.13% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 14.51 K | $7.69 K | 100.00% | 0.09% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 11/12/2025 | 12.78 K | $7.00 K | 0.00% | 0.08% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 12.75 K | $6.76 K | 100.00% | 0.08% |
| BLACKROCK, INC. | 11/12/2025 | 12.38 K | $6.56 K | 0.00% | 0.08% |
| TRUIST FINANCIAL CORP | 11/03/2025 | 10.50 K | $5.57 K | 0.00% | 0.07% |
| ETHOS FINANCIAL GROUP, LLC | 10/23/2025 | 10.03 K | $5.32 K | 100.00% | 0.06% |
| MOORS & CABOT, INC. | 11/14/2025 | 10.00 K | $5.30 K | 100.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 8.38 K | $4.44 K | 113.72% | 0.05% |
| UBS GROUP AG | 11/13/2025 | 3.97 K | $2.10 K | -50.37% | 0.03% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 11/13/2025 | 2.87 K | $1.52 K | 0.00% | 0.02% |
| MORGAN STANLEY | 11/14/2025 | 926 | $491 | 0.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 746 | $395 | 0.00% | 0.00% |
| BOGART WEALTH, LLC | 10/27/2025 | 300 | $159 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 266 | $141 | 82.19% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 43 | $20 | 0.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 10/30/2025 | 34 | $18 | 0.00% | 0.00% |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 10/22/2025 | 17 | $9 | 0.00% | 0.00% |
| NBC SECURITIES, INC. | 11/14/2025 | 14 | $7 | 100.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| ATLANTIC UNION BANKSHARES CORP | 11/04/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STONE HOUSE INVESTMENT MANAGEMENT, LLC | 10/27/2025 | 0 | $0 | -100.00% | 0.00% |
| VERUS CAPITAL PARTNERS, LLC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Moleculin Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Moleculin Biotech, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 239,919
GEODE CAPITAL MANAGEMENT, LLC: 208,210
HRT FINANCIAL LP: 115,190
LPL Financial LLC: 58,080
IEQ CAPITAL, LLC: 36,363
Wealth Dimensions Group, Ltd.: 20,000
5.01% of Moleculin Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 794.19 K shares in the last 24 months. This purchase volume represents approximately $366.68 K in transactions.